These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27254774)

  • 1. ADAMTS5 deficiency protects against non-alcoholic steatohepatitis in obesity.
    Bauters D; Spincemaille P; Geys L; Cassiman D; Vermeersch P; Bedossa P; Scroyen I; Lijnen HR
    Liver Int; 2016 Dec; 36(12):1848-1859. PubMed ID: 27254774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
    Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
    Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
    Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β
    Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
    J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS5 deficiency in mice does not affect cardiac function.
    Hemmeryckx B; Carai P; Roger Lijnen H
    Cell Biol Int; 2019 Jun; 43(6):593-604. PubMed ID: 30958594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
    Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
    Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ADAMTS13 in diet-induced liver steatosis.
    Geys L; Roose E; Vanhoorelbeke K; Bedossa P; Scroyen I; Lijnen HR
    Mol Med Rep; 2017 Aug; 16(2):1451-1458. PubMed ID: 29067443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
    Chiba T; Suzuki S; Sato Y; Itoh T; Umegaki K
    PLoS One; 2016; 11(10):e0164191. PubMed ID: 27723801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of ADAMTS5 in adiposity and metabolic health.
    Bauters D; Bedossa P; Lijnen HR; Hemmeryckx B
    PLoS One; 2018; 13(1):e0190595. PubMed ID: 29293679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS13 deficiency promotes microthrombosis in a murine model of diet-induced liver steatosis.
    Geys L; Bauters D; Roose E; Tersteeg C; Vanhoorelbeke K; Hoylaerts MF; Lijnen RH; Scroyen I
    Thromb Haemost; 2017 Jan; 117(1):19-26. PubMed ID: 27604194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.
    Nozaki Y; Fujita K; Wada K; Yoneda M; Kessoku T; Shinohara Y; Imajo K; Ogawa Y; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
    BMC Gastroenterol; 2015 Apr; 15():42. PubMed ID: 25881230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis.
    Yang Y; Liu X; Chen H; Wang P; Yao S; Zhou B; Yin R; Li C; Wu C; Yang X; Yu M
    FEBS J; 2022 Sep; 289(17):5279-5304. PubMed ID: 35285180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors.
    Ponnusamy S; Tran QT; Thiyagarajan T; Miller DD; Bridges D; Narayanan R
    Exp Biol Med (Maywood); 2017 Mar; 242(6):606-616. PubMed ID: 28092182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAMTS5 promotes murine adipogenesis and visceral adipose tissue expansion.
    Bauters D; Scroyen I; Deprez-Poulain R; Lijnen HR
    Thromb Haemost; 2016 Sep; 116(4):694-704. PubMed ID: 27383908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
    World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice.
    Morrison MC; Mulder P; Salic K; Verheij J; Liang W; van Duyvenvoorde W; Menke A; Kooistra T; Kleemann R; Wielinga PY
    Int J Obes (Lond); 2016 Sep; 40(9):1416-23. PubMed ID: 27121255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.